APPLICATION INFRASTRUCTURE,DATA STORAGE
DigitalOcean | November 16, 2022
DigitalOcean Holdings, Inc., the cloud for developers, startups and SMBs, today announced it is expanding its global presence with a new data center in Sydney, Australia (SYD1). This new facility will better support DigitalOcean’s current and prospective customers who are based in or have end-users in Australia and New Zealand. Sydney is the ninth global region to house a DigitalOcean data center and the fifteenth facility overall.
The SYD1 data center features the most up-to-date network architecture and is connected to DigitalOcean's private internet edge and backbone network, providing 400 Gbps of on-net access to Asia, North America, and Europe. This reduces dependency on public internet and, as a result, mitigates jitter, latency and packet loss for users. All equipment has redundant network and power connections that can route traffic smartly in case of unexpected failures, making for a reliable and secure experience.
“With hundreds of thousands of current customers using our global network today, we’re excited to expand the breadth and capability of our infrastructure to better serve small and medium-sized business (SMB) customers in Australia, New Zealand and the surrounding region. “This state-of-the-art data center will provide low-latency connectivity and our IaaS and PaaS productivity tools for startup businesses and SMBs in these important, rapidly growing markets.”
DigitalOcean CEO, Yancey Spruill
The cloud computing market in Australia is expected to grow 12.5% by 2025, with cloud spending by SMBs expected to grow marginally faster than enterprise organizations. The strong and growing technology business landscape in Australia and in particular Sydney, coupled with the telecommunications connectivity options, including submarine communications cables connecting directly to the United States and Asia, made Sydney an ideal choice for the next DigitalOcean data center.
“This new data center was built with our small business customer’s needs in mind,” said Gabe Monroy, Chief Product Officer at DigitalOcean. “Scalability, availability, and security have been top priorities for our customers and were baked into this build, ensuring that end customers always have a great and secure experience.”
The Sydney facility will provide direct connectivity to the market and improve the overall experience of end customers utilizing applications hosted on the DigitalOcean platform. SYD1 will also provide seamless peering with hyperscalers, making a multi-cloud strategy simple for SMBs and startups who utilize more than one cloud provider.
Beginning today, users can deploy droplets, spin up DigitalOcean Kubernetes clusters, provision a managed database, or utilize any other DigitalOcean product from the SYD1 region.
DigitalOcean simplifies cloud computing so builders can spend more time creating software that changes the world. With its mission-critical infrastructure and fully managed offerings, DigitalOcean helps developers, startups and small and medium-sized businesses (SMBs) rapidly build, deploy and scale applications to accelerate innovation and increase productivity and agility. DigitalOcean combines the power of simplicity, community, open source and customer support so customers can spend less time managing their infrastructure and more time building innovative applications that drive business growth.
HYPER-CONVERGED INFRASTRUCTURE,APPLICATION INFRASTRUCTURE,IT SYSTEMS MANAGEMENT
Effectual | November 09, 2022
Effectual, a modern, cloud first managed and professional services company, has been awarded the HashiCorp Infrastructure Competency as part of the newly released Partner Technical Competency Program for Systems Integrators. Effectual is one of only six companies globally to be recognized with the HashiCorp Infrastructure Competency as part of the program's launch.
As a leader in multi-cloud infrastructure automation software, HashiCorp's software suite enables organizations to adopt consistent workflows and create a system of record for automating the cloud: infrastructure provisioning, security, networking, and application deployment.
The new competency program gives partners with the HashiCorp Systems Integrator designation the opportunity to be recognized for their ability to deliver and integrate HashiCorp products and solutions into end customers' initiatives. Competencies are only awarded after a successful audit that assesses a range of requirements, including the number of technical staff certified on HashiCorp products and proven customer success with HashiCorp products in deployment.
HashiCorp's endorsement gives customers confidence in Effectual's ability to guide, advise, assist, and execute alongside them, bringing the required experience and expertise to succeed with the advantages of HashiCorp's portfolio of automation tools.
"Effectual enables customers to accelerate automation and innovation utilizing HashiCorp Terraform, Vault, and the recently released HCP Boundary. "Together we help customers drive positive business outcomes and realize greater agility, security controls, and increased operational efficiency."
Robb Allen, Effectual CEO
As an elite pure-play AWS services provider, Effectual is a validated AWS MSP Partner holding six AWS competencies. Effectual prides itself on bringing deep cloud and modernization experience to all customer engagements. Complementing this deep partnership with AWS, the cloud first MSP has embraced and invested in its partnership with HashiCorp. This strategic combination of industry expertise ensures that customers have the confidence to migrate and establish a strong modern foundation on which to build and deploy next-generation applications, services, and operations.
An AWS Premier Consulting Partner, Effectual is a modern, cloud first managed and professional services company that works with commercial enterprises and the public sector to enable digital transformation and full stack IT modernization. Effectual's deeply experienced and passionate team of problem solvers apply proven methodologies to enable positive business outcomes with Amazon Web Services and VMware Cloud on AWS. Effectual is a member of the Cloud Security Alliance, and the PCI Security Standards Council.
HYPER-CONVERGED INFRASTRUCTURE, APPLICATION INFRASTRUCTURE
Scale3 Labs | October 07, 2022
Scale3 Labs, a web3 infrastructure company, today announced a $5.3M seed round led by Redpoint Ventures, with participation from Mysten Labs and Howard University.
Operating nodes is extremely complicated with technical know-how being a must. When a problem occurs with a node, the operator must be able to remedy the situation quickly, otherwise time and money are lost. As the number of nodes continues to increase, it's clear that constant monitoring and insight into node performance are critical. Scale3’s inaugural product, Autopilot, aims to simplify and automate the process of standing up, monitoring and upgrading blockchain nodes, assisting node operators to reduce the overall cost of operations. Autopilot leverages open source tooling to provide node operators with blockchain node and network telemetry, community intelligence, and ecosystem specific insights.
“We know first-hand, the challenges of operating and managing node infrastructure at scale. “We are bringing our experience and knowledge to solve this problem and are leveraging best practices and best in class open source tools to reduce the total cost of operations for the industry.”
Karthik Kalyanaraman, CTO of Scale3
Beyond the data and analytics of running nodes, Scale3 is adding monitoring and observability layers via a dashboard that helps node operators to glean information regarding the blockchain community they work within as well as the tooling necessary to manage node upgrades seamlessly.
“Observability in web2 provides an incredibly valuable service. Scale3 has stepped up to provide a solution for the web3 community at a critical time,” said Investor at Redpoint, Urvashi Barooah. “The Scale3 team has expertise building observability tooling from their time at Coinbase, and now they are moving quickly to productize it for a broader market.”
The company plans to use the funding to accelerate development for its suite of web3 tools for blockchain node and network telemetry.
“We are building the web3 observability and monitoring platform for blockchain nodes and networks,” said Ola Muse, CEO of Scale3. “The DevOps for blockchain nodes are a challenge for every node operator, including exchanges, custodians, L1 foundations, staking providers, and node infrastructure providers. We have decades of infrastructure experience and are tackling this problem by building the much-needed standards and tools into our platform to simplify blockchain network and node operations.”
“Simplifying the operational processes associated with maintaining blockchain nodes is key to ensuring the smooth, reliable and scalable operation of decentralized networks,” said Chief Product Officer of Mysten Labs Adeniyi Abiodun. “We are pleased to partner with Scale3 and bring its powerful node monitoring and management tools to the Sui ecosystem.”
Scale3 Autopilot already supports the Sui blockchain network from Mysten Labs and plans to expand support for additional leading blockchain networks in Q4 2022.
About Scale3 Labs
Scale3 Labs is a web3 infrastructure company building developer tools, starting with the monitoring and observability tech stack for blockchain networks and nodes, using the best in class open source software. The team is composed of leading backend infrastructure and distributed systems engineers with years of infrastructure and blockchain experience at Coinbase, Microsoft, Dropbox, VMWare, HP and Consensys.
HYPER-CONVERGED INFRASTRUCTURE, APPLICATION INFRASTRUCTURE
Elucidata | September 27, 2022
Elucidata, a TechBio company that powers life science research & development (R&D) with its data-centric Machine Learning Operations (ML-Ops) platform, Polly, announced that it has raised $16 million in a Series A fundraising today. The round was led by leading global investment firm Eight Roads Ventures, with participation from F-Prime Capital, IvyCap Ventures, and Hyperplane Venture Capital. The newly infused capital will be used to deepen product capabilities in translational drug research and allied markets, scale go-to-market initiatives, and accelerate global expansion of operations.
Successful AI/ML initiatives are built on high-quality data. Elucidata's platform Polly, enables pharmaceutical and diagnostic companies to adopt a data-centric approach for successful AI/ML initiatives. Polly provides R&D teams access to clean, curated biomolecular data that can be queried and analyzed over a graphical user interface (GUI) or programmatically.
Used by leading life sciences companies on over 2.5 million biomolecular datasets, Polly leverages proprietary Bio-NLP technology to rapidly curate biomedical data with human-levels of accuracy, making it machine learning-ready (ML-ready).
"Organizations often underestimate the importance of data quality, and as a result, a lot of AI/ML initiatives are compromised. We're on a mission to derisk such initiatives in life sciences R&D by empowering them with high-quality biomedical data at every stage of the R&D process," said Dr. Abhishek Jha, CEO, and Co-Founder of Elucidata. "The new infusion of capital is a testament to how Polly is creating value for its customers by cleaning and linking data at scale. I am thrilled to have world-class investors at the table as we continue to build a category-defining company.
Elucidata sees the era of AI as one in which life sciences companies leverage the benefits of AI. This would require a complete reimagination of the current "model-centric" AI narrative, that has largely been driven by internet companies, but does not apply to niche industries like life sciences R&D.
"Deciphering insights from biomedical data is at the heart of addressing the world's most important breakthroughs in biopharmaceuticals. There is an explosion in the generation of these complex, heterogeneous datasets, driven by innovations in sequencing technologies and the proliferation of connected devices. Elucidata's technology platform seeks to democratize access to curated biomedical data at scale, allowing biopharmaceutical companies to accelerate the discovery and development of novel therapies. We are proud to partner with Abhishek, Swetabh, and the team on their vision to accelerate data-centric drug discovery and development." said Ashish Venkataramani, Partner, Eight Roads Ventures.
Events of interest in life sciences are rare. Predicting these events is critically dependent on the availability of high-quality data to base the predictive model on, which is a key tenet of the data-centric approach.
"When it comes to AI projects, the quality of labeled data can play a vital role in the difference between success and failure. "Elucidata is providing life science companies access to high-quality datasets and, as a result, effectively accelerating their R&D efforts towards developing innovative solutions that can improve human health."
Nihal Sinha, M.D., Partner at F-Prime Capital
Today, 30+ premier life science companies, including Genentech, Pfizer, Janssen as well as research institutes like Stanford and Bill & Melinda Gates Foundation are leveraging Polly to significantly shorten their drug discovery cycles.
Elucidata was founded in 2015 by University of Chicago and MIT graduate Dr. Abhishek Jha and IIT Delhi alumnus Swetabh Pathak. The company's cutting-edge platform Polly operates on unique Bio-NLP technology that cleans and links 26+ R&D data types and caters to companies in various stages of their drug discovery process. The platform helps data science teams scale by providing them 70 TB of ML-Ready biomedical data, from ~30 public and proprietary sources. Today, 3 of the top 10 pharmaceutical companies are using Polly to fast track their R&D initiatives.
About Eight Roads Ventures
Eight Roads Ventures is a global venture capital firm backed by Fidelity, managing $11 billion of assets across offices in China, India, Japan, the UK, and the U.S. Our 50-year history of investing includes partnerships with over 300 healthcare and technology companies. In May this year, Eight Roads launched its first dedicated US$250 million healthcare and life sciences fund for India. Eight Roads Ventures' India active and exited healthcare partner companies include Ashish Life Science, Caplin Steriles, Carestack, Cipla Health, Core Diagnostics, Denali Therapeutics, Doceree, Eywa Pharma, Elucidata, Immuneel Therapeutics, Laurus Labs, Medwell Ventures, NOCD, Plasmagen Biosciences, Proximie, OZiva, PharmEasy, Richcore Lifesciences, Specsmakers, Spry, Toothsi, Trivitron Healthcare, and Ujala Cygnus.